MedTrace Logo

Prospective Post-market Study Examining the Effectiveness of the EcoFit®

NCT04918680 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-06-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of the EcoFit Hip with implacross E polyethylene for total hip replacement surgery.

Conditions

  • Degenerative Joint Disease
  • Femoral Fracture
  • Osteoarthritis, Hip
  • Traumatic Arthritis

Interventions

DEVICE

EcoFit® Total Hip System with implacross® E Polyethylene

The EcoFit® Total Hip System is a primary hip replacement system indicated for patients who are candidates for a primary cementless hip replacement. implacross® E Polyethylene is one of the components in the EcoFit® system.

Sponsors & Collaborators

  • Implantcast North America, LLC

    lead INDUSTRY

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-21
Primary Completion
2026-12-30
Completion
2027-03-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04918680 on ClinicalTrials.gov